Mr. Gorsky will become the company’s CEO on April 26. He is currently vice chairman of the company’s Executive Committee and will also succeed Mr. Weldon as chairman. Mr. Gorsky began his career with Johnson & Johnson three decades ago as a sales representative and advanced into management positions.
He previously served as president of the company’s subsidiary Janssen Pharmaceutica and served as company group chairman of the pharmaceutical business in Europe, the Middle East and Africa. He has also been the worldwide chairman of the surgical care group.
Related Articles on Orthopedic Device Companies:
Symmetry Medical 4Q Revenue Drops 12%
TranS1 Opens New North Carolina Training Facility
Small Bone Innovations Names Michael Simpson President & CEO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.